Anjushree Lifescience Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 02-11-2024
- Paid Up Capital ₹ 1.50 M
as on 02-11-2024
- Company Age 4 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 11.70 Cr
as on 02-11-2024
- Revenue %
(FY 2023)
- Ebitda
- Net Worth
- Total Assets 947.07%
(FY 2023)
About Anjushree Lifescience
The Company is engaged in the Business Outsourcing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.50 M.
The company currently has active open charges totaling ₹11.70 Cr.
Anju Kumari, Suresh Saini, and Balbir Singh serve as directors at the Company.
- CIN/LLPIN
U24304HP2020PTC008011
- Company No.
008011
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Aug 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Himachal Pradesh
Industry
Company Details
- Location
Solan, Himachal Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Anjushree Lifescience?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anju Kumari  | Director | 12-Aug-2020 | Current |
| Suresh Saini | Director | 12-Aug-2020 | Current |
| Balbir Singh | Additional Director | 13-Mar-2023 | Current |
Financial Performance of Anjushree Lifescience.
Anjushree Lifescience Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Anjushree Lifescience?
Unlock access to Anjushree Lifescience's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Septy Pharmaceuticals Private LimitedActive 18 years 7 monthsAnju Kumari and Suresh Saini are mutual person
Innocosmetica Wellness LimitedActive 9 months 12 daysAnju Kumari and Suresh Saini are mutual person
- Septy Biosciences Private LimitedActive 2 years 5 months
Anju Kumari and Suresh Saini are mutual person
- Alkon Formulation Private LimitedActive 7 years 11 months
Anju Kumari and Suresh Saini are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 12 Sep 2024 | ₹8.70 Cr | Open |
Axis Bank Limited Creation Date: 29 Sep 2022 | ₹3.00 Cr | Open |
How Many Employees Work at Anjushree Lifescience?
Anjushree Lifescience has a workforce of 0 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Anjushree Lifescience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Anjushree Lifescience's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
